Pay in installments of $5.07 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
For Your Every Summer RSVP, with Code: SUMMER15
Description
Buy Semaglutide Online Finding Best Place to Get Semaglutide for Weight Loss Can You Drink Soda on Semaglutide? Effects and Better Options Fella Health GLP 1 Tirzepatide Oral Tablet Weight Loss Sublingual Pills Semaglutida GLP 1 en Tampa Vital Advanced Medical Center Semaglutide Wikipedia
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 26 reviews
Sort
Product Reviews
★★★★★ 5
Amazing
Format: Paperback
Such an amazing book of information I learned so much about this has tons of professionals and tips
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 8, 2024
★★★★★ 5
good deal
Format: Paperback
great book
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 28, 2025
★★★★★ 4
Sets you up for success in the Real Estate Business
If you are preparing to become successful in the Real Estate department this is the book for you. If you have some Financal stability and determination you could pull off everything you learn in this book. Easy read, very informative, talks about all the important aspects of the business of investments in real estate. They give great examples through real life stories which really makes it a good read if you simply like hearing success stories for inspiration in your own life.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 25, 2011
★★★★★ 5
Worth every penny!
Format: Paperback
Had the version on Audible finding the quick reference of a hard copy invaluable as I learn more and develop my processes to create financial freedom.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 28, 2025
★★★★★ 5
Excellent Reading for Real Estate Investors
This book is worth it's weight in gold! I've liked all of Kiyosaki's books and courses but this one really stands out.
Mr. Kiyosaki has brought together some brilliant minds and what they wrote is easy to understand and makes absolute sense.
As an investor specializing in lease options, I tried to do it all on my own and got 4 contracts but then they were not with motivated sellers.
While reading this book, it became very clear to me the importance of having a team of people to help you out. My biggest take away is "Investing is a team sport." Yes, I know that's a 'no-brainer' but now I truly realize what he and the others who contributed are trying to say in this volume.
Lately, I've switched over to specializing in tax deeds and liens and the chapter on lien investing by Mr. Wheelright is very good - he makes it very simple and easy to understand.
I highly recommend this book. It is in the top 3 books on real estate investing that I've ever read, and I'm a book and seminar junkie. Get this book today!!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 20, 2009
recommand products
The FDA just approved Ozempic for kidney disease
24.66
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
29.59
FDA approves Ozempic to reduce the risk of kidney disease worsening, kidney failure and death due to CV disease in adults with type 2 diabetes and CKD - Novo Nordisk
24.09
Effects of Once-Weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial
26.23
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
25.39